Results 121 to 130 of about 24,684 (197)

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization [PDF]

open access: yes, 2018
Background: Macular choroidal neovascularization (CNV) is one of the most vision-threatening complications of myopia, which can lead to severe vision loss.
Ambresin, Aude   +4 more
core  

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting

open access: yesClinical Ophthalmology, 2012
Angela M Carneiro,1,2 Luis S Mendonça,1 Manuel S Falcão,1,2 Sofia L Fonseca,1 Elisete M Brandão,1 Fernando M Falcão-Reis1,21Department of Ophthalmology of Hospital de São João, Porto ...
Carneiro AM   +5 more
doaj  

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance

open access: yesClinical Ophthalmology, 2018
Ali Dirani, Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland Purpose: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after ...
Dirani A, Mantel I
doaj  

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

open access: yesClinical Ophthalmology, 2013
Michael A Singer,1 Steven R Cohen,2 Sylvia L Groth,3 Salman Porbandarwalla21Medical Center Ophthalmology Associates (MCOA), San Antonio, Texas, USA; 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio ...
Singer MA   +3 more
doaj  

Home - About - Disclaimer - Privacy